A Study Comparing Ponatinib and Nilotinib in Participants With Chronic Myeloid Leukemia

NCT02627677 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
44
Enrollment
INDUSTRY
Sponsor class

Stopped The study was stopped due to operational feasibility and not due to any safety concerns

Conditions

Interventions

Sponsor

Ariad Pharmaceuticals